Longitudinal Comparison of Neutralizing Antibody Responses to COVID-19 mRNA Vaccines after Second and Third Doses

COVID-19 mRNA vaccines protect against severe disease and hospitalization. Neutralizing antibodies (NAbs) are a first-line defense mechanism, but protective NAb responses are variable. Currently, NAb testing is not widely available. This study employed a lateral flow assay for monitoring NAb levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Roeder, Alexa J., Koehler, Megan A., Jasbi, Paniz, McKechnie, Davis, Vanderhoof, John, Edwards, Baylee A., Gonzalez-Moa, Maria J., Seit-Nebi, Alim, Svarovsky, Sergei A., Lake, Douglas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504054/
https://www.ncbi.nlm.nih.gov/pubmed/36146537
http://dx.doi.org/10.3390/vaccines10091459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504054/
https://www.ncbi.nlm.nih.gov/pubmed/36146537
http://dx.doi.org/10.3390/vaccines10091459

Ejemplares similares